Daewoong Bio has always grown
together with people.
To help patients and their families
live healthier and happier lives,
we first challenged ourselves in the central nervous system (CNS)
field.
Through continuous research and effort, we have achieved the No.1 position in Korea
in this field today.

This achievement was only possible
thanks to the trust of our customers.

However, our journey did not stop there.

We have expanded into the circulatory and endocrine fields
that treat chronic diseases such as hypertension and diabetes,
as well as the respiratory and antibiotic fields needed for treating
colds, respiratory illnesses, and infections,
bringing our solutions closer
to the lives of more people.

In addition, through our active pharmaceutical ingredient (API)
business, Daewoong Bio provides safer and more reliable

pharmaceutical products—from raw materials to finished medicines.

Based on accumulated research and data,
Daewoong Bio continues to open new paths for treatment
and strives to bring hope to patients and their families.

Going forward, Daewoong Bio will continue to discover better treatments
through innovative research and remain by the side of
our trusted customers, partners, and patients.
Through steady growth, we aim to become
a globally recognized pharmaceutical company.

Our journey is far from over.
To create a healthier tomorrow than today,
Daewoong Bio will always move forward
together with you.

Thank you.

Sincerely, Jinseong Gon CEO